HIPEC

You have access
Interval Cytoreductive Surgery and Heated Intraperitoneal Chemotherapy for Ovarian Cancer: Report of a Single-center Experience
CHRYSOULA LIAKOU, ANASTASIOS PANDRAKLAKIS, MARIA-CLELIA LA RUSSA, HILARY TURNBULL, JOAQUIN NIETO, TIMOTHY DUNCAN, ADAM STEARNS and NIKOLAOS BURBOS

Anticancer Research October 2023, 43 (10) 4593-4599; DOI: https://doi.org/10.21873/anticanres.16653
Open Access
Cytoreductive Surgery and HIPEC for Malignant Peritoneal Mesothelioma: Outcomes and Survival From an Australian Centre
RAPHAEL SHAMAVONIAN, ERNEST CHENG, JOSH B. KARPES, SHOMA BARAT, NIMA AHMADI and DAVID L. MORRIS

Anticancer Research June 2022, 42 (6) 2939-2944; DOI: https://doi.org/10.21873/anticanres.15776
You have access
Hyperthermia During Intraperitoneal Chemotherapy With Paclitaxel or Docetaxel for Ovarian Cancer: Is There Any Benefit?
EELCO DE BREE, DESPOINA KATSOUGKRI, HARA POLIOUDAKI, ELENA TSANGARIDOU, DIMOSTHENIS MICHELAKIS, ODYSSEAS ZORAS and PANAYIOTIS THEODOROPOULOS

Anticancer Research December 2020, 40 (12) 6769-6780; DOI: https://doi.org/10.21873/anticanres.14700
You have access
Outcome in Patients Treated With Cytoreductive Surgery and HIPEC for Gastric Cancer With Peritoneal Carcinomatosis
FRANZISKA BRAEUER, INES FISCHER, LINDSAY BRAMMEN, GERD PRESSL, REINHOLD FUEGGER, KLEMENS ROHREGGER and HELWIG WUNDSAM

Anticancer Research April 2020, 40 (4) 2151-2156; DOI: https://doi.org/10.21873/anticanres.14174
You have access
Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Ovarian Cancer: Evaluation of Side Effects in a Single Institution Cohort
MICHAEL FRIEDRICH, WOLFGANG ZINN, LAURA KOLNSBERG, CLAYTON KRAFT and WALTHER KUHN

Anticancer Research March 2020, 40 (3) 1481-1486; DOI: https://doi.org/10.21873/anticanres.14092
You have access
Malignant Peritoneal Mesothelioma: Treatment Options and Survival
SILJA A.S. SALO, ILKKA ILONEN, SANNA LAAKSONEN, MARJUKKA MYLLÄRNIEMI, JARMO A. SALO and TUOMO RANTANEN

Anticancer Research February 2019, 39 (2) 839-845; DOI: https://doi.org/10.21873/anticanres.13183
You have access
Iterative Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Recurrent Peritoneal Metastases
ANTONIO SOMMARIVA, MARCO TONELLO, CAMILLA CONA, PIERLUIGI PILATI and CARLO RICCARDO ROSSI

Anticancer Research September 2018, 38 (9) 5521-5524; DOI: https://doi.org/10.21873/anticanres.12886
You have access
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Elderly Patients: Complete Cytoreduction Is Feasible and Crucial for Improved Survival Despite High Carcinomatosis Index
SAMER A. NAFFOUJE and GEORGE I. SALTI

Anticancer Research January 2018, 38 (1) 441-448;
You have access
Response of OVCAR-3 Cells to Cisplatin and Hyperthermia: Does Hyperthermia Really Matter?
ARTURAS SUKOVAS, VAIDOTAS CESNA, ALDONA JASUKAITIENE, GIEDRIUS BARAUSKAS, RUTA JOLANTA NADISAUSKIENE, ZILVINAS DAMBRAUSKAS, SAULIUS PASKAUSKAS and ANTANAS GULBINAS

Anticancer Research September 2017, 37 (9) 5011-5018;
You have access
Strategies for Preventing Pseudomyxoma Peritonei After Resection of a Mucinous Neoplasm of the Appendix
CHARLES HONORÉ, FRANCESCO CARUSO, PEGGY DARTIGUES, LÉONOR BENHAIM, MIRCEA CHIRICA, DIANE GOÉRÉ and DOMINIQUE ELIAS

Anticancer Research September 2015, 35 (9) 4943-4947;

Main menu

User menu

Search

HIPEC

Pages